EGLN1 antibody (AA 1-24)
Quick Overview for EGLN1 antibody (AA 1-24) (ABIN7868900)
Target
See all EGLN1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 1-24
-
Purpose
- EGLN1 Antibody / PHD2
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Amino acids 1-24 of human PHD2/EGLN1 were used as the immunogen for the EGLN1 antibody.
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal dilution of the EGLN1 / PHD2 antibody should be determined by the researcher.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.2 mg/mL
-
Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the EGLN1 / PHD2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1 (EGLN1))
-
Alternative Name
- EGLN1
-
Background
- 366G/76/3 recognises human prolyl hydroxylase 2 (PHD2), a 46 kDa enzyme expressed abundantly in all tissues with the highest expression in testis. Hypoxia inducible factor-1 (HIF-1) is a transcriptional complex, consisting of an alpha and beta subunit, which plays a key role in coordinating the cellular response to hypoxia. During normal oxygen conditions, the alpha subunit of HIF-1 is rapidly degraded, however when hypoxia occurs this degradation is suppressed and HIF-1 activates the transcription of various genes important for survival and adaptation to hypoxia. Prolyl hydroxylase 2 catalyses the hydroxylation of specific prolyl residues within the HIF-1 alpha subunit, thereby targeting this subunit for degradation.
-
UniProt
- Q9GZT9
-
Pathways
- cAMP Metabolic Process, Warburg Effect
Target
-